glp-1 macular degeneration Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling Studies Suggest GLP-1 Drug Use
Description
Crump, R
It contributes 3-5% to the GLP-1 pharmaceutical ecosystem, primarily supporting users of semaglutide and tirzepatide
48: e12935
both are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN-2
That said, some people already work with a nutritionist or have a solid dietary foundation and may not need this level of support
